Skip to main content

Table 2 PEF analyses as a percentage of personal best PEF

From: Effect of adjusting the combination of budesonide/formoterol on the alleviation of asthma symptoms

  Total Fixed-dose group Adjusted-dose group
Mean (%) 89.8 ± 5.6 89.3 ± 7.6 90.2 ± 3.8
CV (standard deviation/mean) 0.045 ± 0.022 0.044 ± 0.022 0.047 ± 0.023
Minimum/Maximum 0.74 ± 0.13 0.75 ± 0.15 0.72 ± 0.12
Morning – evening (%) − 1.03 ± 1.65 −1.23 ± 1.38 −0.88 ± 1.86
Mean PEF with symptoms (%):
 Cough 87.1 ± 6.8 85.4 ± 8.0 88.1 ± 6.2
 Dyspnea 85.5 ± 7.9 82.6 ± 10.9 86.8 ± 6.4
 Wheeze 83.6 ± 7.7 81.8 ± 11.6 84.2 ± 6.5
Mean PEF in each month (%):
 January 88.5 ± 6.2 87.5 ± 8.5 89.2 ± 4.3
 February 89.0 ± 7.8 85.8 ± 11.1 90.7 ± 5.3
 March 87.9 ± 8.2 85.6 ± 11.2 89.4 ± 5.6
 April 88.9 ± 7.1 85.6 ± 10.7 90.5 ± 4.0
 May 88.8 ± 5.5 88.0 ± 7.1 89.3 ± 4.5
 June 89.5 ± 7.9 88.4 ± 10.3 90.2 ± 6.5
 July 90.3 ± 7.4 87.7 ± 10.8 92.2 ± 3.1
 August 90.5 ± 6.9 88.8 ± 10.0 91.7 ± 3.7
 September 90.8 ± 6.5 90.2 ± 9.3 91.1 ± 3.8
 October 90.1 ± 5.7 90.0 ± 7.3 90.2 ± 4.5
 November 89.2 ± 6.7 89.5 ± 8.3 89.0 ± 5.6
 December 88.3 ± 6.5 88.0 ± 8.3 88.5 ± 5.2
  1. Mean ± SD
  2. No significant differences between the fixed-dose and adjusted-dose groups